Rosie Bradbury

4 days ago | pitchbook.com | Rosie Bradbury

Loic Venance/Getty Images Sequoia is the latest blue-chip VC to invest in an indie cinema powerhouse: It led a consortium to invest $100 million in art house streaming service Mubi, valuing the company at $1 billion. It represents part of a growing interest among VCs in investing in media and entertainment production companies.

1 week ago | pitchbook.com | Rosie Bradbury

Michael Kovac/Getty Images As AI reshapes the world, global competition, particularly from China, poses potentially major risks to the world order, famed investor Mary Meeker warned in a new report. In the exhaustive 340-page report published Friday, Meeker, managing partner at Bond Capital, painted a picture of the near future where AI is as ubiquitous as the internet.

1 week ago | pitchbook.com | Jessica Hamlin |Rosie Bradbury

Taylor Swift is private equity’s new antihero. The 14-Grammy-winning artist repurchased her catalog of music from Shamrock Capital, after the buyout firm bought the rights in 2020 from her then-manager Scooter Braun’s Ithaca Holdings, according to a statement on Swift’s official website. “All I’ve ever wanted was the opportunity to work hard enough to be able to one day purchase my music outright.” Swift wrote in the statement.

1 week ago | pitchbook.com | Rosie Bradbury

As private capital liquidity continues to be sparse, one piece of the equation is becoming even trickier for emerging managers and mid-career investors: the GP commit. A new startup, Henry Capital, just raised a $3.5 million seed round led by Alleycorp to help alleviate that problem. It offers credit lines to managing partners and principals looking to buy into their firm’s vehicles, as well as emerging GPs setting up their own shops.

2 weeks ago | pitchbook.com | Rosie Bradbury

Digital health startup Hinge Health saw a 17% IPO pop on its first day of trading on the New York Stock Exchange, closing the day at $37.56 a share. Hinge Health and its selling shareholders raised $437 million in the IPO, which priced shares at $32 each for a fully diluted market cap of about $3.5 billion. The debut is a long-awaited windfall for early investors Atomico, 11.2 Capital and Insight Partners, and the first major public listing of a VC-backed healthtech company since 2021.